title: Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo.
abstract: The impact of immune sera, and peripheral blood cells (PBC) from mice immunized with Plasmodium berghei ookinetes; and of purified immunoglobulin or Fab fragments from anti-Pbs21 monoclonal antibody 13.1, upon establishment of oocyst infections in the mosquito was studied. Infections were initiated either from gametocyte-infected mice, or membrane feeders which contained either gametocytes or mature ookinetes. PBC from ookinete-immunized mice presented with non-immune serum failed to show any transmission-blocking activity. Anti-ookinete serum, intact anti-Pbs21 monoclonal antibody 13.1 or its Fab fragments, all inhibited oocyst formation significantly. When gametocyte-infected mice or gametocytes in membrane feeds were used, inhibition did not directly correlate with antibody concentration. In membrane feeders that contained ookinetes and antibody, concentration-dependent inhibition usually occurred. The efficacy of purified 13.1 IgG was dependent upon the ookinete concentration. The ookinete plasmalemma and cytoplasm were significantly disturbed after 12 h in bloodmeals that contained antibody 13.1, but not in the isotype controls. These changes may have caused the observed failure of the ookinete to migrate as rapidly as the controls from the destructive environment of the bloodmeal.
authors.affiliation: Department of Biology, Imperial College, London.
authors.forename: G R
authors.initials: GR
authors.lastname: Ranawaka
authors.forename: S L
authors.initials: SL
authors.lastname: Fleck
authors.forename: A R
authors.initials: AR
authors.lastname: Blanco
authors.forename: R E
authors.initials: RE
authors.lastname: Sinden
mesh_terms: D000818:Animals; D000852:Anopheles / Q000469:parasitology / Q000648:ultrastructure; D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D001667:Binding, Competitive; D004064:Digestive System / Q000469:parasitology / Q000648:ultrastructure; D005260:Female; D007109:Immunity; D007116:Immunization, Passive; D007303:Insect Vectors; D008288:Malaria / Q000276:immunology* / Q000517:prevention & control; D017780:Malaria Vaccines / Q000494:pharmacology; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D010962:Plasmodium berghei / Q000254:growth & development / Q000276:immunology* / Q000648:ultrastructure; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D000913:Antibodies, Protozoan; D017780:Malaria Vaccines